These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 24633355)
1. Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer. Starmer HM; Yang W; Raval R; Gourin CG; Richardson M; Kumar R; Jones B; McNutt T; Cheng Z; Quon H Dysphagia; 2014 Jun; 29(3):396-402. PubMed ID: 24633355 [TBL] [Abstract][Full Text] [Related]
2. One-Year Swallowing Outcomes in Patients Treated with Prophylactic Gabapentin During Radiation-Based Treatment for Oropharyngeal Cancer. Starmer HM; Yang W; Gourin CG; Kumar R; Jones B; McNutt T; Cheng S; Quon H Dysphagia; 2017 Jun; 32(3):437-442. PubMed ID: 28204979 [TBL] [Abstract][Full Text] [Related]
3. Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer. Kataoka T; Kiyota N; Shimada T; Funakoshi Y; Chayahara N; Toyoda M; Fujiwara Y; Nibu K; Komori T; Sasaki R; Mukohara T; Minami H Auris Nasus Larynx; 2016 Dec; 43(6):677-84. PubMed ID: 26992271 [TBL] [Abstract][Full Text] [Related]
4. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma. Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211 [TBL] [Abstract][Full Text] [Related]
5. Gabapentin for the treatment of pain syndrome related to radiation-induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapy. Bar Ad V; Weinstein G; Dutta PR; Dosoretz A; Chalian A; Both S; Quon H Cancer; 2010 Sep; 116(17):4206-13. PubMed ID: 20564146 [TBL] [Abstract][Full Text] [Related]
6. Swallowing outcomes for patients with oropharyngeal squamous cell carcinoma treated with primary (chemo)radiation therapy receiving either prophylactic gastrostomy or reactive nasogastric tube: A prospective cohort study. Goff D; Coward S; Fitzgerald A; Paleri V; Moor JW; Patterson JM Clin Otolaryngol; 2017 Dec; 42(6):1135-1140. PubMed ID: 28128886 [TBL] [Abstract][Full Text] [Related]
7. Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of Gabapentin. Yang W; McNutt TR; Dudley SA; Kumar R; Starmer HM; Gourin CG; Moore JA; Evans K; Allen M; Agrawal N; Richmon JD; Chung CH; Quon H Dysphagia; 2016 Apr; 31(2):206-13. PubMed ID: 26753929 [TBL] [Abstract][Full Text] [Related]
8. Role of Gabapentin in Managing Mucositis Pain in Patients Undergoing Radiation Therapy to the Head and Neck. Milazzo-Kiedaisch CA; Itano J; Dutta PR Clin J Oncol Nurs; 2016 Dec; 20(6):623-628. PubMed ID: 27857262 [TBL] [Abstract][Full Text] [Related]
9. It is not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy. Naik M; Ward MC; Bledsoe TJ; Kumar AM; Rybicki LA; Saxton JP; Burkey BB; Greskovich JF; Adelstein DJ; Koyfman SA Oral Oncol; 2015 Aug; 51(8):800-4. PubMed ID: 25977228 [TBL] [Abstract][Full Text] [Related]
10. Quality-of-life scores compared to objective measures of swallowing after oropharyngeal chemoradiation. Kendall KA; Kosek SR; Tanner K Laryngoscope; 2014 Mar; 124(3):682-7. PubMed ID: 23929736 [TBL] [Abstract][Full Text] [Related]
11. Swallowing outcomes in patients with oropharyngeal cancer undergoing organ-preservation treatment. Starmer HM; Tippett D; Webster K; Quon H; Jones B; Hardy S; Gourin CG Head Neck; 2014 Oct; 36(10):1392-7. PubMed ID: 24038454 [TBL] [Abstract][Full Text] [Related]
12. Long-term swallow function after chemoradiotherapy for oropharyngeal cancer: the influence of a prophylactic gastrostomy or reactive nasogastric tube. Prestwich RJ; Teo MT; Gilbert A; Williams G; Dyker KE; Sen M Clin Oncol (R Coll Radiol); 2014 Feb; 26(2):103-9. PubMed ID: 24246275 [TBL] [Abstract][Full Text] [Related]
13. Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy. Maggiore RJ; Curran EK; Witt ME; Haraf DJ; Vokes EE; Cohen EE J Geriatr Oncol; 2013 Oct; 4(4):327-33. PubMed ID: 24472475 [TBL] [Abstract][Full Text] [Related]
14. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence. Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563 [TBL] [Abstract][Full Text] [Related]
15. Impact of prophylactic gastrostomy or reactive NG tube upon patient-reported long term swallow function following chemoradiotherapy for oropharyngeal carcinoma: A matched pair analysis. Sethugavalar B; Teo MT; Buchan C; Ermiş E; Williams GF; Sen M; Prestwich RJD Oral Oncol; 2016 Aug; 59():80-85. PubMed ID: 27424186 [TBL] [Abstract][Full Text] [Related]
16. Gabapentin attenuates late but not early postoperative pain after thyroidectomy with superficial cervical plexus block. Brogly N; Wattier JM; Andrieu G; Peres D; Robin E; Kipnis E; Arnalsteen L; Thielemans B; Carnaille B; Pattou F; Vallet B; Lebuffe G Anesth Analg; 2008 Nov; 107(5):1720-5. PubMed ID: 18931238 [TBL] [Abstract][Full Text] [Related]